U
SGYPW

UBS’s Synergy Pharmaceuticals, Inc. - Warrants SGYPW Stock Holding History

UBS’s Portfolio SGYPW Stock Details SGYPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Buy
1,709
+400
+31% +$486 ﹤0.01% 10231
2014
Q2 		$2K Buy
+1,309
New +$2.14K ﹤0.01% 10131
2014
Q1 		– Sell
-615
Closed -$1K – 11158
2013
Q4 		$1K Buy
+615
New +$1.01K ﹤0.01% 10256

Other funds holding SGYPW

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS's SGYPW Position: Q3 2014 in Review

UBS increased its Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) stake by 31% in Q3 2014, buying an estimated $486 and bringing the position to 1,709 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #10231.

UBS first reported a position in SGYPW in Q4 2013 and has held it in 3 quarters since. The position peaked at $2K in Q2 2014. 5 funds tracked by Wall St. Rank hold SGYPW as of Q3 2014.

  • UBS held 1,709 shares of Synergy Pharmaceuticals, Inc. - Warrants worth $1K as of Q3 2014.
  • UBS bought 400 Synergy Pharmaceuticals, Inc. - Warrants shares in Q3 2014, an estimated $486.
  • Synergy Pharmaceuticals, Inc. - Warrants made up ﹤0.01% of UBS's portfolio in Q3 2014, its #10231 holding.
  • UBS first reported a position in Synergy Pharmaceuticals, Inc. - Warrants in Q4 2013 and has held it in 3 quarters since.
  • UBS's Synergy Pharmaceuticals, Inc. - Warrants position peaked at $2K in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc. - Warrants as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.